Abnormal Fibrinogens with Two Structural Defects
Among the abnormal fibrinogens which we recently analyzed, two types of abnormality were found to have two structural defects: a genetically determined amino acid substitution and an additional secondary modification of the molecule due to the mutation (1, 2). Here we briefly describe these abnormal molecules.
Unable to display preview. Download preview PDF.
- 2.K. Yamazumi, K. Shimura, S. Terukina, N. Takahashi and M. Matsuda, A γ-methionine310 to threonine substitution and consequent N-glycosylation at γ asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi, J. Clin. Invest., 83:1590 (1989).PubMedCrossRefGoogle Scholar
- 8.C. Southan, A. Henschen and F. Lottspeich, The search for molecular defects in abnormal fibrinogens, in: “Fibrinogen, Recent Biochemical and Medical Aspects,” A. Henschen, H. Graeff and F. Lottspeich, eds., Walter de Gruyter, Berlin (1982).Google Scholar
- 9.T. Miyata, S. Terukina, M. Matsuda, A. Kasamatsu, Y. Takeda, T. Murakami and S. Iwanaga, Fibrinogens Kawaguchi and Osaka: An amino acid substitution of Aα arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two Aα chains, J. Biochem., 102:93 (1987).PubMedGoogle Scholar